CELEBRATION, FL – DR LOTENFOE at UROLOGY HEALTH SOLUTIONS today announced that their first patient has been treated with the UroLift® System, the first permanent implant to treat symptoms due to benign prostatic hyperplasia (BPH, enlarged prostate) in men 50 years of age or older. Cleared by the U.S. Food and Drug Administration in 2013, the UroLift System is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function.
“Our clinic is committed to providing patients with the highest quality, most effective and minimally invasive options to address their urology needs,” said Dr. Lotenfoe. “The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. More importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients with generally less permanent side effects than medications or other types of surgery.”
The UroLift System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime.
Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most post-procedure symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
About BPH Treatment
More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, retrograde ejaculation, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the ‘gold standard’ Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation (dry orgasm).
The UroLift System provides an alternative to tissue-removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift System to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift implants to hold the prostate lobes in the retracted position. This opens the urethra while leaving the prostate intact. Adverse reactions associated with UroLift System treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. The most common adverse events reported during the study included pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.
For more information on this innovative system, visit our website: www.OrlandoUrologistMD.com. If you would like to know if you are a candidate for this procedure, please schedule a consultation with Dr. Lotenfoe by calling 407-566-1105. He has offices in Celebration, FL, Winter Haven, FL, and Poinciana, FL.
Richard R. Lotenfoe, M.D. is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He has been in practice for 22 years and specializes in the minimally and extreme minimally invasive treatments for urological conditions and diseases such as enlarged prostates, prostate cancer, erectile dysfunction and bladder dysfunction. Look up more information about Dr. Lotenfoe and his practice at www.OrlandoUrologistMD.com. For an appointment with Dr. Lotenfoe, please call 407-566-1105.
Company Name: Urology Health Solutions
Contact Person: Tabitha Baker
Address:410 Celebration Place Suite 201
State: FL, 34747
Country: United States